7.66
-0.26 (-3.28%)
| Previous Close | 7.92 |
| Open | 7.87 |
| Volume | 77,734 |
| Avg. Volume (3M) | 130,018 |
| Market Cap | 96,192,480 |
| Price / Sales | 14.99 |
| Price / Book | 13.64 |
| 52 Weeks Range |
| Profit Margin | -286.19% |
| Operating Margin (TTM) | -187.13% |
| Diluted EPS (TTM) | -1.23 |
| Quarterly Revenue Growth (YOY) | 38.50% |
| Total Debt/Equity (MRQ) | 150.39% |
| Current Ratio (MRQ) | 1.21 |
| Operating Cash Flow (TTM) | -6.37 M |
| Levered Free Cash Flow (TTM) | -4.49 M |
| Return on Assets (TTM) | -220.12% |
| Return on Equity (TTM) | -2,480.49% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Neuraxis, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Relative Valuation | NA |
| Financial Health | -2.5 |
| AI Insight | NA |
| Weighted Average | 0.50 |
Select this tab to load the latest available analysis.
|
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 25.71% |
| % Held by Institutions | 11.95% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rosalind Advisors, Inc. | 30 Jun 2026 | 508,055 |
| Money Concepts Capital Corp | 30 Jun 2026 | 228,029 |
| Parsons Capital Management Inc/Ri | 30 Jun 2026 | 117,808 |
| Panoramic Capital, Llc | 30 Jun 2026 | 115,000 |
| Eddie Patel Inc | 30 Jun 2026 | 59,764 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CARRICO BRIAN ALLEN | 6.77 | - | 268 | 1,814 |
| CARRICO THOMAS JOESEPH | 6.77 | - | 328 | 2,221 |
| HENRICHS TIMOTHY ROBERT | 6.77 | - | 1,937 | 13,113 |
| Aggregate Net Quantity | 2,533 | |||
| Aggregate Net Value ($) | 17,148 | |||
| Aggregate Avg. Buy ($) | 6.77 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HENRICHS TIMOTHY ROBERT | Officer | 08 Oct 2026 | Buy (+) | 1,937 | 6.77 | 13,113 |
| CARRICO THOMAS JOESEPH | Officer | 08 Oct 2026 | Buy (+) | 328 | 6.77 | 2,221 |
| CARRICO BRIAN ALLEN | Officer | 08 Oct 2026 | Buy (+) | 268 | 6.77 | 1,814 |
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |